ClassID:

96404

C07H15/252 - CPC Classification

Classification description:

Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals; Carbocyclic rings; Condensed ring systems having three or more rings Naphthacene radicals, e.g. daunomycins, adriamycins

Recent Application in this class:
#1
20260132164
2026-05-14

PNU ANTHRACYCLINE DERIVATIVES AND METHODS OF USE THEREOF

#2
20260078012
2026-03-19

NANOPARTICLE COMPOSITION AND METHOD OF USE AND MANUFACTURE

#3
20260015595
2026-01-15

ENGINEERED GLYCOSYLTRANSFERASES AND STEVIOL GLYCOSIDE GLUCOSYLATION METHODS

#4
20260008804
2026-01-08

FLUORINATED BENZOYL ANTHRACYCLINE DERIVATIVES, AND PREPARATION AND APPLICATIONS OF SAME

#5
20250228778
2025-07-17

PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION

#6
20240010999
2024-01-11

ENGINEERED GLYCOSYLTRANSFERASES AND STEVIOL GLYCOSIDE GLUCOSYLATION METHODS

#7
20230391731
2023-12-07

PRODRUGS FOR SUSTAINED RELEASING THERAPEUTIC AGENTS AND USES THEREOF

#8
20220250932
2022-08-11

METHOD OF TREATING CANCER WITH A METALLIC NANOPARTICLE COMPOSITION

#9
20210177758
2021-06-17

Platform drug delivery system utilizing crystal engineering and theanine dissolution

#10
20210137957
2021-05-13

MODIFIED ANTHRACYCLINE COMPOUNDS AND THEIR THERAPEUTIC USE

#11
20210130182
2021-05-06

Therapeutic metallic nanoparticle composition and method of use and manufacture thereof

#12
20210047338
2021-02-18

MODIFIED CYTOTOXINS AND THEIR THERAPEUTIC USE

#13
20210002320
2021-01-07

CHEMICALLY CLEAVABLE GROUP

#14
20200399296
2020-12-24

Non-aqueous electrolytic solution for power storage element

#15
20200247842
2020-08-06

Immune-stimulating soluble doxorubicin-conjugated complex

#16
20200032227
2020-01-30

Engineered glycosyltransferases and steviol glycoside glucosylation methods

#17
20190382432
2019-12-19

STABLE CRYSTALLINE MONOHYDRATE OF EPIRUBICIN HYDROCHLORIDE AND METHOD OF PRODUCTION

#18
20190381179
2019-12-19

MODIFIED CYTOTOXINS AND THEIR THERAPEUTIC USE

#19
20190262464
2019-08-29

Antibody-drug-conjugates comprising novel anthracycline-derivatives for cancer treatment

#20
20190135858
2019-05-09

Legumain Activated Doxorubicin Derivative as well as Preparation Method and Application Thereof

#21
20190100548
2019-04-04

Anthracycline Derivatives For Treating Tumor Diseases

#22
20190016747
2019-01-17

PURIFIED REBAUDIOSIDE A

#23
20180303808
2018-10-25

Combination therapy for treating malignancies

#24
20180237461
2018-08-23

Phosphoric acid diester salt, production method therefor, non-aqueous electrolytic solution for power storage element, and power storage element

#25
20180230175
2018-08-16

3′-deamino-3′-(2″-pyrroline-1″-yl)-5-imino-13-deoxyanthracyclines and methods of preparation

#26
20180222915
2018-08-09

Modified cytotoxins and their therapeutic use

#27
20180094014
2018-04-05

Method of producing epirubicin and novel production intermediate thereof

#28
20180000951
2018-01-04

Modified cytotoxins and their therapeutic use

#29
20170189431
2017-07-06

Anticancer agents of the anthracyclin family

#30
20170106094
2017-04-20

Legumain activated doxorubicin derivative as well as preparation method and application thereof

#31
20170080094
2017-03-23

Modified cytotoxins and their therapeutic use

#32
20170051001
2017-02-23

Purification of epidaunorubicin

#33
20160137685
2016-05-19

NUCLEOSIDE PHOSPHORAMIDATES AND PHOSPHORAMIDITES

#34
20160137683
2016-05-19

Method for preparing epirubicin and intermediate thereof

#35
20160068558
2016-03-10

Anticancer agents of the anthracyclin family

#36
20150344514
2015-12-03

Chemically cleavable group

#37
20150299241
2015-10-22

METHOD FOR PREPARING HIGHLY PURE DOXORUBICIN

#38
20150252069
2015-09-10

Anthracycline derivatives for treating tumor diseases

#39
20140378673
2014-12-25

Prodrug using nitroimidazole

#40
20140357848
2014-12-04

Crystalline 4′-epidaunorubicin hydrochloride and use thereof

#41
20140350230
2014-11-27

Multi-functional nucleic acid-based anti-cancer drug capable of targeting and therapy, method for preparing same and anti-cancer composition comprising same

#42
20140343261
2014-11-20

SORBENT COMPRISING ON ITS SURFACE AN ALIPHATIC UNIT HAVING AN ANIONIC OR DEPROTONIZABLE GROUP FOR THE PURIFICATION OF ORGANIC MOLECULES

#43
20140315255
2014-10-23

NOVEL ANTIBACTERIAL COMPOUNDS, METHODS OF MAKING THEM, AND USES THEREOF

#44
20140271874
2014-09-18

STABLE CRYSTALLINE MONOHYDRATE OF EPIRUBICIN HYDROCHLORIDE AND METHOD OF PRODUCTION

#45
20140228311
2014-08-14

CRYSTALLIZATION OF IDARUBICIN HYDROCHLORIDE

#46
20140148587
2014-05-29

Crystalline 4′-epidaunorubicin hydrochloride and use thereof

#47
20140051623
2014-02-20

Bisphosphonate-prodrugs

#48
20140011759
2014-01-09

Compositions and methods of treatment of drug resistant cancers

#49
20130237490
2013-09-12

NOVEL ANTIBACTERIAL COMPOUNDS, METHODS OF MAKING THEM, AND USES THEREOF

#50
20130144045
2013-06-06

Self-reactive arms and prodrugs comprising same

#51
20130131001
2013-05-23

Epirubicin derivatives

#52
20120309948
2012-12-06

Crystallization of epirubicin hydrochloride

#53
20120277415
2012-11-01

Method of producing 4-demethoxydaunorubicin

#54
20120232291
2012-09-13

Crystallization of 4′-epidaunorubicin hydrochloride

#55
20120202761
2012-08-09

Compositions and methods of improving the tolerability of daunorubicin when given as orotate salt

#56
20120171229
2012-07-05

SYNTHETIC NANOCARRIERS WITH REACTIVE GROUPS THAT RELEASE BIOLOGICALLY ACTIVE AGENTS

#57
20120148595
2012-06-14

GABA-LINKED ANTHRACYCLINE-LIPID CONJUGATES

#58
20120010163
2012-01-12

Antibacterial compounds, methods of making them, and uses thereof

#59
20110251380
2011-10-13

Rebaudioside A Purification Method

#60
20110224161
2011-09-15

Tetracyclic anthraquinone antibiotic derivatives with high activity, process for preparing the same and use thereof

#61
20110207918
2011-08-25

PURE AND SUBSTANTIALLY PURE REBAUDIOSIDE A

#62
20110136752
2011-06-09

NOVEL ANTIBIOTICS

#63
20110124587
2011-05-26

Pure Rebaudioside A

#64
20110021452
2011-01-27

LYOPHILIZED PREPARATION OF STABILIZED ANTHRACYCLINE COMPOUNDS

#65
20100279958
2010-11-04

Compounds and methods for inhibiting selectin-mediated function

#66
20100137206
2010-06-03

NOVEL LIGAND GUIDED BLOCK COPOLYMERS FOR TARGETED DRUG DELIVERY

#67
20100035799
2010-02-11

METHOD FOR THE SYNTHESIS OF ANTHRACYCLINE-PEPTIDE CONJUGATES

#68
20090247623
2009-10-01

Derivatives of epirubicin, their medicinal application and pharmaceuticaly acceptable forms of drugs

#69
20090227617
2009-09-10

Esters Of Glucuronide Prodrugs Of Anthracyclines And Method Of Preparation And Use In Tumor-Selective Chemotherapy

#70
20090176974
2009-07-09

Method of aralkylation of 4′-hydroxyl group of anthracylins

#71
20090170941
2009-07-02

Pharmaceutical compounds

#72
20090131344
2009-05-21

Method of reducing cardiac levels of doxorubicin when given as orotate salt

#73
20080214648
2008-09-04

Hiv Prodrugs Cleavable by Cd26

#74
20080175789
2008-07-24

Modified PSMA ligands and uses related thereto

#75
20080153899
2008-06-26

FATTY AMINE DRUG CONJUGATES

#76
20080139490
2008-06-12

Crystalline forms of valrubicin and processes for their preparation

#77
20080039421
2008-02-14

Molecular transporters based on alditol or inositol and processes for the preparation thereof

#78
20080027144
2008-01-31

Benzonaphthacene glycoside derivative and use thereof

#79
20080025949
2008-01-31

Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives

#80
20070275900
2007-11-29

Prodrugs cleavable by CD26

#81
20070207196
2007-09-06

TOCOPHEROL-MODIFIED THERAPEUTIC DRUG COMPOUND FORMULATIONS

#82
20070202574
2007-08-30

Novel Saccharothrix Strain an Antibiotics Derived Therefrom, i.e. Mutactimycins and Aldgamycins

#83
20070197499
2007-08-23

Pharmaceutical compounds

#84
20070178487
2007-08-02

Active-site engineering of nucleotidylyltransferases and general enzymatic methods for the synthesis of natural and “unnatural” UDP- and TDP-nucleotide sugars

#85
20070142309
2007-06-21

Synthesis of epirubicin from 13-dihydrodaunorubicine

#86
20070059689
2007-03-15

Hybrid glycosylated products and their production and use

#87
20070037758
2007-02-15

Anthracycline antibiotics and methods of treating cancer using the same

#88
20060276418
2006-12-07

Multidrug resistant anticancer anthracyclines

#89
20060247185
2006-11-02

Stabilization of amrubicin hydrochloride

#90
20060229359
2006-10-12

Tocopherol-modified therapeutic drug compounds

#91
20060223766
2006-10-05

Epimerization of 4′-C bond and modification of 14-CH-(CO)-fragment in anthracyclin antibiotics

#92
20060205684
2006-09-14

METHOD OF PREPARING 4-R-SUBSTITUTED 4-DEMETHOXYDAUNORUBICIN

#93
20060194745
2006-08-31

Compounds and methods for inhibiting selectin-mediated function

#94
20060173161
2006-08-03

Protein-binding doxorubicin peptide derivatives

#95
20060083838
2006-04-20

High yield method of producing pure rebaudioside A

#96
20060030605
2006-02-09

Nitroderivatives of cardiovascular agents

#97
20060003949
2006-01-05

Freeze-dried preparation of stabilized anthracycline compound

#98
20050282759
2005-12-22

Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

#99
20050245486
2005-11-03

Modified PSMA ligands and uses related thereto

#100
20050239688
2005-10-27

Method for the synthesis of anthracycline-peptide conjugates

#101
20050209174
2005-09-22

Molecular conjugates for use in treatment of cancer

#102
20050123533
2005-06-09

Prodrugs activated by targeted catalytic proteins

#103
20050101775
2005-05-12

Prodrugs for liver specific drug delivery

#104
20050096340
2005-05-05

Tocopherol-modified therapeutic drug compounds

#105
20050004048
2005-01-06

Methods and compositions for the manufacture of C-3′ and C-4′ anthracycline antibiotics

#106
14327597
2015-12-22

Anticancer agents of the anthracyclin family